Evidence map›Paper›PMID 22581993›Full record

ArticleJournal of the American Society of Nephrology : JASN2012

Human AKI and heme oxygenase-1.

Karl A Nath

Abstract readEditorialComment
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Oxidative stress in chronic kidney disease.Pediatric nephrology (Berlin, Germany) · 2019
    Review
  5. Article
  6. Heme Oxygenase-1 Gene Polymorphisms-Toward Precision Medicine for AKI.Journal of the American Society of Nephrology : JASN · 2016
    Article
  7. Review
  8. Article
  9. Heme oxygenase-1 and acute kidney injury.Current opinion in nephrology and hypertension · 2014
    Review
  10. Renal cortical hemopexin accumulation in response to acute kidney injury.American journal of physiology. Renal physiology · 2012
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Karl A Nath

Funding

VASCULAR PATHOBIOLOGY OF SICKLE CELL DISEASEP01HL055552 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HEBBEL, ROBERT P · 1995 to 2011
$17.3M
Renal Injury and Adaptation to Heme ProteinsR37DK047060 · NIDDK · MAYO CLINIC ROCHESTER · PI NATH, KARL A. · 2002 to 2011
$3.6M
RENAL INJURY AND ADAPTATION TO HEME PROTEINSR01DK047060 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI NATH, KARL A. · 1993 to 2018
$2.2M
NHLBI NIH HHS HL55552NHLBI NIH HHS P01 HL055552NIDDK NIH HHS DK47060NIDDK NIH HHS R01 DK047060NIDDK NIH HHS R37 DK047060
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Kidney InjuryAnimalsHeme Oxygenase-1HumansKidney Failure, ChronicKidney Tubules, ProximalMaleHeme Oxygenase-1

Identifiers

PMID22581993
PMCPMC3358770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.